Electromed logo
Electromed ELMD
$ 29.6 0.27%
report update icon

Quarterly report 2026-Q4
added 08-25-2026

Electromed Income Statement 2026-2010 | ELMD

Brief overview of income trends at Electromed

The conclusions below are based on five years of reported results. The revenue attributed to Electromed moved from $32.5 million to $64 million between the two endpoints. Overall revenue changed by +97.1%, equal to an annualized rate of about 14.5%. The company expanded its sales base at a healthy rate.

Gross profit was 25.2 million dollars at the start and 50 million dollars at the end of the period (+98.3%). Revenue and direct costs changed at similar rates. Gross margin moved from 77.6% to 78.1%. Gross profitability remained broadly stable.

EBITDA was $5.9 million at the beginning and $10.7 million at the end of the period (+82.7%). EBITDA lagged revenue, showing weaker operating momentum. EBITDA margin moved from 18% to 16.7%. The EBITDA margin stayed near its previous level.

The five-year change in net income was +81.1%: from 4.2 million dollars to 7.5 million dollars. Net profit ended the five years at a local peak.

Market capitalization changed from 148 million dollars to 175 million dollars (+18.2%). The financial trend was stronger than the market valuation.

Financial takeaway

The results present an uneven picture without one dominant signal. Key strengths include a stronger final result, revenue expansion and steady gross profitability. The overall view is constrained by weaker operating efficiency. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.

Annual Income Statement Electromed

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Market Cap

325 M 175 M 137 M 83 M 78.2 M 103 M 148 M 44.4 M 43.3 M 50.3 M 36.2 M 14.6 M 11.3 M 9.66 M 16.2 M 26.6 M -

Shares

8.27 M 8.45 M 8.56 M 8.46 M 8.47 M 8.57 M 8.4 M 8.31 M 8.21 M 8.17 M 8.14 M 8.12 M 8.11 M 8.11 M 8.11 M 7.82 M -

Historical Prices

39.3 20.7 16.1 9.81 9.23 12.9 9.94 9.74 5.69 5.62 3.96 1.62 2.29 1.7 1.35 3 -

Net Income

11.3 M 7.54 M 5.15 M 3.17 M 2.3 M 2.36 M 4.16 M 1.97 M 1.9 M 2.23 M 2.21 M 1.09 M -1.29 M -1.33 M 187 K 1.06 M -

Revenue

73.8 M 64 M 54.7 M 48.1 M 41.7 M 35.8 M 32.5 M 31.3 M 28.7 M 25.9 M 23 M 19.4 M 15.5 M 15.1 M 19.5 M 19 M -

Cost of Revenue

15.8 M 14 M 13 M 11.5 M 10.2 M 8.45 M 7.27 M 7.45 M 6.53 M 5.29 M 5.12 M 5.81 M 4.85 M 4.66 M 5.38 M 5.23 M -

Gross Profit

57.9 M 50 M 41.7 M 36.5 M 31.4 M 27.3 M 25.2 M 23.8 M 22.9 M 20.6 M 17.9 M 13.6 M 10.6 M 10.4 M 14.1 M 13.8 M -

Operating Income

13.9 M 9.66 M 6.58 M 4.01 M 2.97 M 3.14 M 5.12 M 2.83 M 2.71 M 3.57 M 3.11 M 1.31 M -741 K -1.83 M 606 K 1.87 M -

Interest Expense

- - 455 K 78 K 25 K 27 K 121 K 90.7 K 19.9 K -49.9 K -66.8 K 85.7 K 79 K 117 K 169 K 191 K -

EBITDA

14.7 M 10.7 M 7.37 M 4.56 M 3.48 M 3.62 M 5.86 M 3.74 M 3.8 M 4.32 M 3.85 M 2.05 M -45 K -1.24 M 1.14 M 2.32 M -

Operating Expenses

44.1 M 40.3 M 35.1 M 32.5 M 28.5 M 24.2 M 20.1 M 21 M 19.8 M 17 M 14.8 M 12.3 M 11.4 M 12.3 M 13.5 M 11.9 M -

General and Administrative Expenses

42.7 M 39.3 M 34.5 M 31.6 M 27.1 M 22.4 M 19.9 M 20.4 M 19.6 M 16.4 M 14.4 M 12 M 10.9 M 11.7 M 12.6 M 10.9 M -

All numbers in USD currency

Quarterly Income Statement Electromed

2026-Q4 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 8.21 M 8.27 M 8.32 M 8.27 M 8.32 M 8.35 M 8.5 M 8.42 M 8.56 M 8.64 M 8.57 M 8.55 M 8.54 M 8.56 M 8.46 M 8.44 M 8.45 M 8.48 M 8.45 M 8.48 M 8.56 M 8.5 M 8.58 M 8.57 M 8.55 M 8.57 M 8.55 M 8.39 M 8.38 M 8.39 M 8.38 M 8.3 M 8.26 M 8.3 M 8.26 M 8.2 M 8.2 M 8.2 M 8.2 M 8.17 M 8.17 M 8.17 M 8.17 M 8.13 M 8.13 M 8.13 M 8.13 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.11 M 8.1 M 8.1 M 8.1 M 8.1 M

Net Income

- 3 M 2.76 M 2.14 M 2.76 M 2.14 M - 1.89 M 1.97 M 1.47 M - 1.49 M 1.67 M 155 K - 1.08 M 977 K 81 K 1.06 M 645 K 838 K 439 K 1.28 M 439 K 1.2 M 1.2 M 1.2 M 535 K 1.19 M 1.19 M 1.19 M 1.01 M 381 K 378 K 378 K 154 K 420 K 81 K 349 K 121 K 444 K 191 K 444 K 191 K 1.07 M 341 K 1.07 M 341 K 423 K 378 K 423 K 378 K -239 K -335 K -239 K -335 K -411 K -71.1 K -411 K -71.1 K 24.6 K 246 K 24.6 K 246 K

Revenue

- 18.6 M 18.9 M 16.9 M 18.9 M 16.9 M - 15.7 M 16.3 M 14.7 M - 13.9 M 13.7 M 12.3 M - 12.1 M 11.7 M 10.7 M 22.4 M 10.1 M 10.2 M 10 M 20.2 M 8.79 M 9.5 M 8 M 9.5 M 8 M 8.55 M 8.3 M 8.55 M 8.3 M 8.01 M 7.28 M 8.01 M 7.28 M 6.96 M 6.3 M 6.98 M 6.38 M 6.37 M 5.55 M 6.37 M 5.55 M 6.26 M 5 M 6.26 M 5 M 4.88 M 4.77 M 4.88 M 4.77 M 3.5 M 3.42 M 3.5 M 3.42 M 3.86 M 4.03 M 3.86 M 4.03 M 4.79 M 5.38 M 4.79 M 5.38 M

Cost of Revenue

- 3.93 M 4.08 M 3.69 M 4.08 M 3.69 M - 3.46 M 3.63 M 3.18 M - 3.49 M 3.14 M 2.83 M - 3.01 M 3.05 M 2.33 M 5.37 M 2.4 M 2.37 M 2.3 M 4.67 M 2.09 M 1.97 M 1.86 M 1.97 M 1.86 M 1.87 M 1.96 M 1.87 M 1.96 M 1.95 M 1.73 M 1.95 M 1.73 M 1.56 M 1.61 M 1.4 M 1.45 M 1.45 M 1.22 M 1.45 M 1.22 M 1.36 M 1.14 M 1.36 M 1.14 M 1.48 M 1.48 M 1.48 M 1.48 M 978 K 1.06 M 978 K 1.06 M 1.34 M 1.21 M 1.34 M 1.21 M 1.31 M 1.31 M 1.31 M 1.32 M

Gross Profit

- 14.6 M 14.8 M 13.2 M 14.8 M 13.2 M - 12.2 M 12.6 M 11.5 M - 10.4 M 10.5 M 9.5 M - 9.06 M 8.68 M 8.33 M 17 M 7.74 M 7.88 M 7.7 M 15.6 M 6.7 M 7.52 M 6.15 M 7.53 M 6.15 M 6.68 M 6.34 M 6.68 M 6.34 M 6.06 M 5.54 M 6.06 M 5.54 M 5.4 M 4.69 M 5.59 M 4.94 M 4.93 M 4.33 M 4.93 M 4.33 M 4.9 M 3.86 M 4.9 M 3.86 M 3.4 M 3.29 M 3.4 M 3.29 M 2.52 M 2.36 M 2.52 M 2.36 M 2.51 M 2.82 M 2.51 M 2.82 M 3.48 M 4.07 M 3.48 M 4.06 M

Operating Income

- 3.77 M 3.62 M 2.67 M 3.62 M 2.67 M - 2.14 M 2.54 M 1.94 M - 1.84 M 2.26 M 142 K - 1.2 M 1.27 M 44 K 1.32 M 863 K 1.08 M 538 K 1.61 M 243 K 1.58 M 663 K 1.58 M 663 K 1.57 M 1.35 M 1.57 M 1.35 M 675 K 202 K 672 K 199 K 771 K 99.2 K 770 K 162 K 729 K 289 K 729 K 289 K 1.25 M 585 K 1.25 M 585 K 447 K 398 K 447 K 398 K -309 K -577 K -309 K -577 K -595 K -96.4 K -595 K -96.4 K 100 K 452 K 100 K 452 K

Interest Expense

- - - - - - - - 152 K 195 K - 120 K 96 K 77 K - 26 K 7 K 4 K 11 K 6 K 6 K 9 K 15 K 10 K 9.71 K 9 K 19 K 9.28 K 37.1 K 40 K 37.1 K 40 K 16.5 K 13.5 K 16.5 K 13.5 K -4.89 K -4.2 K -4.89 K -4.2 K -15.6 K -16.7 K -15.6 K -16.7 K -17.9 K 20.2 K -17.9 K 20.4 K 24.7 K 20.5 K 45.1 K 20.5 K 19.5 K 15.2 K 19.5 K 15.2 K 25.8 K 36.7 K 25.8 K 36.7 K 43.6 K 43.9 K 43.6 K 43.9 K

EBITDA

- 4.41 M 4.05 M 2.88 M - 2.88 M - - - 2.14 M - - - 344 K - - 1.27 M 178 K 1.59 M 863 K 1.08 M 644 K 1.84 M 243 K 1.58 M 795 K 1.83 M 795 K 1.57 M 1.5 M 1.89 M 1.5 M 675 K 367 K 1 M 364 K 771 K 263 K 1.1 M 326 K 729 K 445 K 1.04 M 445 K 1.25 M 740 K 1.56 M 740 K 447 K 553 K 756 K 553 K -309 K -454 K -49.7 K -454 K -595 K 18.6 K -363 K 18.6 K 100 K 543 K 294 K 543 K

Operating Expenses

- 10.9 M 11.2 M 10.5 M 11.2 M 10.5 M - 10.1 M 10.1 M 9.55 M - 8.54 M 8.28 M 9.36 M - 7.86 M 7.41 M 8.29 M 15.7 M 6.88 M 6.8 M 7.16 M 14 M 6.46 M 5.94 M 5.48 M 5.94 M 5.49 M 5.11 M 4.99 M 5.11 M 4.99 M 5.39 M 5.34 M 5.39 M 5.34 M 4.63 M 4.59 M 4.82 M 4.77 M 4.2 M 4.04 M 4.2 M 4.04 M 3.65 M 3.27 M 3.65 M 3.27 M 2.96 M 2.9 M 2.96 M 2.9 M 2.83 M 2.93 M 2.83 M 2.93 M 3.11 M 2.92 M 3.11 M 2.92 M 3.38 M 3.62 M 3.38 M 3.61 M

General and Administrative Expenses

- 10.5 M 10.8 M 10.3 M 10.8 M 10.3 M - 9.81 M 9.83 M 9.39 M - 8.37 M 8.18 M 9.15 M - 7.69 M 7.25 M 7.99 M 15.2 M 6.54 M 6.48 M 6.79 M 13.3 M 6.05 M 5.44 M 5 M 5.44 M 5 M 4.97 M 4.89 M 4.97 M 4.89 M 5.15 M 5.27 M 5.15 M 5.28 M 4.58 M 4.52 M 4.76 M 4.7 M 4.1 M 3.69 M 4.1 M 3.69 M 3.59 M 3.23 M 3.59 M 3.23 M 2.87 M 2.82 M 2.87 M 2.82 M 2.74 M 2.72 M 2.74 M 2.72 M 3 M 2.82 M 3 M 2.82 M 3.13 M 3.4 M 3.13 M 3.4 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Electromed (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 57.08 3.84 % $ 8.66 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 15.55 0.18 % $ 440 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.8 6.24 % $ 642 M israelIsrael
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.71 0.69 % $ 12 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 80.32 0.36 % $ 4.38 B britainBritain
LENSAR LENSAR
LNSR
$ 8.3 0.24 % $ 99.3 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.34 0.15 % $ 21.2 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Butterfly Network Butterfly Network
BFLY
$ 8.43 0.93 % $ 2.08 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 125.33 0.02 % $ 4.35 B usaUSA